Reference health
A comparative study of the efficacy of NAXOZOL compared to celecoxib in patients with osteoarthritis
26/26 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 26 checked references that resolve
resolves10.1001/archinte.160.19.2998
Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis
resolves10.1186/ar1704
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
resolves10.1111/j.1365-2036.2006.03210.x
Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non‐steroidal anti‐inflammatory drugs
resolves10.1111/j.1572-0241.2006.00499.x
Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors
resolves10.1111/j.1365-2036.2010.04361.x
Clinical trial: evaluation of gastric acid suppression with three doses of immediate‐release esomeprazole in the fixed‐dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric‐coated esomeprazole 20 mg: a randomized, open‐label, Phase I study in healthy volunteers
resolves10.3109/07853890.2011.625971
A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: Results from two randomized, parallel-group, placebo-controlled trials
resolves10.1111/j.1365-2036.2010.04378.x
Clinical trial: the incidence of NSAID‐associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric‐coated naproxen alone
resolves10.1185/03007995.2011.555756
Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers
resolves10.1517/14656566.2014.911841
Treatment of gastroesophageal reflux disease: two new oral formulations dexlansoprazole MR and esomezol (esomeprazole strontium)
resolves10.2147/DDDT.S86725
Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers
resolves10.1111/j.1572-0241.2005.40701.x
Valdecoxib Is Associated with Improved Dyspepsia-Related Health Compared with Nonspecific NSAIDs in Patients with Osteoarthritis or Rheumatoid Arthritis
resolves10.1136/ard.2009.113100
EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis
resolves10.1046/j.1365-2036.1998.00404.x
The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia
resolves10.1007/BF01535722
GSRS?A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease
resolves10.1016/S1063-4584(03)00082-7
Response relationship of VAS and Likert scales in osteoarthritis efficacy measurement
resolves10.1016/0168-8510(90)90421-9
EuroQol - a new facility for the measurement of health-related quality of life
resolves10.1111/j.1572-0241.2005.41465.x
Improvements with Esomeprazole in Patients with Upper Gastrointestinal Symptoms Taking Non-Steroidal Antiinflammatory Drugs, Including Selective COX-2 Inhibitors
resolves10.1111/j.1572-0241.2001.03932.x
Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments
resolves10.1111/jcpt.12484
Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis
resolves10.2147/DHPS.S7329
Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease
The 3 references without a DOI — listed, not checked
no DOI — not checkedGuidelines for prevention of NSAID-related ulcer complications
no DOI — not checkedEfficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses
no DOI — not checkedIn brief: Esomeprazole strontium
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1371/journal.pone.0226184"><img src="https://citestamp.com/citestamped/10.1371/journal.pone.0226184/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1371/journal.pone.0226184)